New therapies for myelofibrosis Published 2020-09-10 Download video MP4 360p Recommendations 07:58 Dr. Mikhael on Challenges, Advances in Multiple Myeloma Treatment 04:02 Moving CAR-T therapy into earlier lines of treatment for myeloma and the need for effective bridging 1:08:56 Pharmacokinetic Guided Dosing of Hydroxyurea 2:43:17 What To Eat & When To Eat! - How To Burn Fat, Repair The Body & Prevent Disease | Dr. William Li 01:41 Predicting outcomes in patients with R/R MM undergoing CAR T-cell therapy: the MyCARe model 04:57 Analysis of clinical outcomes & HRU in patients with AML treated with venetoclax vs other therapies 08:11 Improvements over time in elderly patients with AML treated with alloSCT: an EBMT Registry study 04:34 What Is the Future for CAR-T in Multiple Myeloma? 01:49 The management of Richter's transformation: current approaches and future outlooks 18:56 Why I Take Hydroxyurea (for Sickle Cell Disease)– An Unpopular Opinion 04:04 Overcoming challenges in CAR T-cell therapy for multiple myeloma Similar videos 02:33 Optimizing current treatment approaches in myelofibrosis 01:15 Exploring the evolving treatment landscape of myelofibrosis 04:49 Myelofibrosis - causes, symptoms, diagnosis, treatment, pathology 03:19 First-line treatment selection in myelofibrosis 02:01 Early myelofibrosis: current treatment approaches and novel strategies 10:27 New Treatment Options for Myelofibrosis and Acute Myeloid Leukemia 01:01 Latest advances in myelofibrosis treatment 03:00 Myelofibrosis - Mayo Clinic 05:26 Myelofibrosis Explained: What You Need to Know 02:55 IMpactMF: imetelstat vs best available therapy in patients with myelofibrosis 00:57 Myelofibrosis treatment in 5 years 29:46 Exciting Advances in Myelofibrosis Treatments | What Patients NEED to know NOW! | The Patient Story 04:01 Treatment for Primary Myelofibrosis 17:41 For Myelofibrosis Patients: The Latest on Promising Treatments from Top Specialist | Dr. Ruben Mesa 04:58 Treatment of Myelofibrosis: Emerging Therapies 01:28 Comorbidities and treatment decisions in myelofibrosis 01:31 Promising agents under investigation for the treatment of myelofibrosis with cytopenia 01:18 Novel approaches for the treatment of myelofibrosis: navitoclax + ruxolitinib 01:30 LCL161 for primary myelofibrosis: a new therapy in the field More results